FDA approves experimental stem cell therapy to help deaf ear repair itself

ear

The Food and Drug Administration (FDA) has recently approved a groundbreaking trial by the University of Texas Medical School at Houston to evaluate the safety of using a child’s own cord blood stem cells to regenerate damaged cells in the inner ear and potentially restore the child’s hearing. Just as antibiotics changed the treatment of infections, stem cells may revolutionize the future of nervous system repair.

View the original article here: FDA approves experimental stem cell therapy to help deaf ear repair itself

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend